FrancophonIA/ELRC3.0 huggingface dataset:
English: Temporary or permanent discontinuation of Natpar must be accompanied by monitoring of serum calcium levels and increase of exogenous calcium and/or active vitamin D sources as necessary.
Danish: Ved midlertidig behandlingsafbrydelse eller permanent seponering af Natpar skal serumcalcium monitoreres, og tilskuddet af eksogent calcium og/eller aktivt D-vitamin skal om nødvendigt øges.
English: Figure T
Danish: Figur T
English: Figure M
Danish: Figur M
English: No drug-drug interaction study has been conducted with cardiac glycosides and Natpar (see section 4.4).
Danish: Der er ikke gennemført interaktionsstudier med hjerteglykosider og Natpar (se pkt.
English: Figure F
Danish: Figur F
English: Figure W
Danish: Figur W
English: Natpar 50 micrograms
Danish: Natpar 50 mikrogram
English: Figure P
Danish: Figur P
English: Contents of the pack and other information 7 Instructions for use
Danish: Pakningsstørrelser og yderligere oplysninger 7.
English: • Keep the mixed pen tightly closed in order to protect from light.
Danish: • Hold den rekonstituerede pen tæt tillukket for at beskytte mod lys.
English: Natpar 25 micrograms
Danish: Natpar 25 mikrogram
English: The response of serum calcium concentration to administration of Natpar should be monitored at intervals to detect this and the diagnosis of tachyphylaxis considered.
Danish: For at holde øje med, om dette sker, bør responsen på Natpar-administration i form af serumcalcium-niveauet monitoreres regelmæssigt, og takyfylaksi bør i givet fald overvejes.
English: Hypercalcaemia
Danish: Hyperkalcæmi
English: Figure G
Danish: Figur G
English: If you use more Natpar than you should
Danish: Hvis du har taget for meget Natpar
English: There are no data available in patients with severe renal impairment (see section 4.4).
Danish: Der foreligger ingen data for patienter med svært nedsat leverfunktion (se pkt.
English: E. SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES
Danish: E. SÆRLIG FORPLIGTELSE TIL AT AFSLUTTE FORANSTALTNINGER EFTER UDSTEDELSE AF MARKEDSFØRINGSTILLADELSE TIL LÆGEMIDLER GODKENDT UNDER BETINGEDE OMSTÆNDIGHEDER
English: Figure N
Danish: Figur N
English: Figure R
Danish: Figur R
English: Figure U
Danish: Figur U
English: In the liver, parathyroid hormone is cleaved by cathepsins.
Danish: I leveren spaltes parathyroideahormon af cathepsiner.
English: Temporary or permanent discontinuation of Natpar treatment must be accompanied by monitoring of serum calcium levels and adjustment, as necessary, of exogenous calcium and/or active vitamin D (see section 4.4).
Danish: Ved midlertidig eller permanent seponering af Natpar skal serumcalcium monitoreres, og tilskuddet af eksogent calcium og/eller aktivt D-vitamin skal om nødvendigt justeres (se pkt.
English: Missed dose
Danish: Hvis en dosis glemmes
English: Decrease
Danish: Reducér
English: Initiating Natpar
Danish: Start af behandling med Natpar
English: Figure K
Danish: Figur K
English: Cases of hypocalcaemia resulting in seizures have been reported post-marketing (see section 4.4).
Danish: Efter markedsføring er der rapporteret tilfælde af hypokalcæmi, der førte til slagtilfælde (se pkt.
English: Cardiac disorders palpitations*
Danish: Hjerte palpitationer*
English: 3 • Pick up the needle and peel the paper tab back from the needle cap (See Figure F).
Danish: 3 • Tag nålen og fjern papirforseglingen fra kanylehætten (se figur F).
English: abdominal pain upper*
Danish: øvre abdominalsmerter*
English: Adjust second
Danish: Justér dernæst
English: Figure E
Danish: Figur E
English: Tests and checks
Danish: Blodprøver og urinprøver
English: You should save the pen and call Shire at +44 (0)800 055 6614 to discuss getting a replacement.
Danish: Du skal gemme pennen og ringe til Shire på +44 (0)800 055 6614 for at få en erstatning.
English: Call Shire at +44 (0)800 055 6614 for help.
Danish: Ring til Shire på +44 (0)800 055 6614 for at få hjælp.
English: For any drug that affects serum calcium levels (e.g., lithium, thiazides), patients' serum calcium levels should be monitored.
Danish: Patientens serumcalcium skal monitoreres ved behandling med ethvert lægemiddel, der påvirker serumcalcium (f.eks. lithium, thiazider).
English: Each pre-filled pen contains 700 micrograms parathyroid hormone (rDNA).
Danish: Hver fyldt pen indeholder 700 mikrogram parathyroideahormon (rDNA).
English: Each pre-filled pen contains 1050 micrograms parathyroid hormone (rDNA).
Danish: Hver fyldt pen indeholder 1.050 mikrogram parathyroideahormon (rDNA).
English: The objective of this trial was to maintain serum calcium with Natpar while reducing or replacing oral calcium and active vitamin D. The study was a 24-week, randomised, double-blind, placebo-controlled, multicentre trial.
Danish: Studiet var et 24-ugers, randomiseret, dobbeltblindet, placebo-kontrolleret multicenterstudie.
English: Natpar 25 micrograms/dose powder and solvent for solution for injection in pre-filled pen Natpar 50 micrograms/dose powder and solvent for solution for injection in pre-filled pen Natpar 75 micrograms/dose powder and solvent for solution for injection in pre-filled pen Natpar 100 micrograms/dose powder and solvent for solution for injection in pre-filled pen
Danish: Natpar 25 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 50 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 75 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 100 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen
English: Each pre-filled pen contains 350 micrograms parathyroid hormone (rDNA).
Danish: Hver fyldt pen indeholder 350 mikrogram parathyroideahormon (rDNA).
English: People may need between 25 and100 micrograms of Natpar per day.
Danish: Den daglige dosis kan variere fra 25 til 100 mikrogram Natpar.
English: What Natpar is and what it is used for 2.
Danish: Virkning og anvendelse 2.
English: Natpar 25 microgram/dose powder and solvent for solution for injection in pre-filled pen Natpar 50 microgram/dose powder and solvent for solution for injection in pre-filled pen Natpar 75 microgram/dose powder and solvent for solution for injection in pre-filled pen Natpar 100 microgram/dose powder and solvent for solution for injection in pre-filled pen Parathyroid hormone (rDNA)
Danish: Natpar 25 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 50 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 75 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Natpar 100 mikrogram/dosis pulver og solvens til injektionsvæske, opløsning i fyldt pen Parathyroideahormon (rDNA)
English: How to use Natpar
Danish: Sådan skal du tage Natpar
English: Natpar 25 micrograms/dose
Danish: Natpar 25 mikrogram/dosis Lilla etiket.
English: Hepatic impairment
Danish: Psykiske forstyrrelser angst
English: • need to pass urine often
Danish: • hyppig vandladning
English: vomiting*
Danish: • mavesmerter*
English: Natpar 75 micrograms/dose
Danish: Natpar 75 mikrogram/dosis Grå etiket.
English: If it does not, call Shire at +44 (0)800 055 6614 for help.
Danish: Hvis det ikke er tilfældet, skal du ringe til Shire på +44 (0)800 055 6614 for at få hjælp.
English: Each pre-filled pen contains 1400 micrograms parathyroid hormone (rDNA).
Danish: Hver fyldt pen indeholder 1.400 mikrogram parathyroideahormon (rDNA).
English: This means that there is more evidence to come about this medicine.
Danish: Dette indikerer, at medicinen er begyndt at blive leveret.
English: The MAH shall complete, within the stated timeframe, the below measures:
Danish: • Forpligtelse til at gennemføre foranstaltninger efter udstedelse af markedsføringstilladelse Indehaveren af markedsføringstilladelsen skal inden for den fastsatte tidsramme gennemføre følgende foranstaltninger:
English: , nausea*,
Danish: , kvalme*, opkastning*
English: 16 • Squeeze the needle cap and unscrew the needle (See Figure W).
Danish: 16 • Klem på kanylehætten og skru kanylen af (se figur W).
English: How long to use
Danish: Så længe skal du tage Natpar
English: Natpar 25 mcg/dose powder for solution for injection Natpar 50 mcg/dose powder for solution for injection Natpar 75 mcg/dose powder for solution for injection Natpar 100 mcg/dose powder for solution for injection Parathyroid hormone (rDNA) Subcutaneous use
Danish: Natpar 25 mikrogram/dosis pulver til injektionsvæske, opløsning Natpar 50 mikrogram/dosis pulver til injektionsvæske, opløsning Natpar 75 mikrogram/dosis pulver til injektionsvæske, opløsning Natpar 100 mikrogram/dosis pulver til injektionsvæske, opløsning Parathyroideahormon (rDNA)
English: Each dose contains 100 micrograms parathyroid hormone (rDNA) in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 100 mikrogram parathyroideahormon (rDNA) i 71,4 mikroliter-opløsning efter rekonstitution.
English: • headaches*
Danish: • hovedpine*,
English: Each pre-filled pen contains 700 micrograms of parathyroid hormone (rDNA) as powder in the first chamber and 1000 microlitres of solvent in the second chamber (corresponding to 14 doses).
Danish: Hver fyldt pen indeholder 700 mikrogram parathyroideahormon (rDNA) som pulver i det ene kammer og 1.000 mikroliter solvens i det andet kammer (svarende til 14 doser).
English: • muscle spasms
Danish: • muskelsmerter
English: Each pre-filled pen contains 350 micrograms of parathyroid hormone (rDNA) as powder in the first chamber and 1000 microlitres of solvent in the second chamber (corresponding to 14 doses).
Danish: Hver fyldt pen indeholder 350 mikrogram parathyroideahormon (rDNA) som pulver i det ene kammer og 1.000 mikroliter solvens i det andet kammer (svarende til 14 doser).
English: Each dose contains 100 micrograms parathyroid hormone in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 100 mikrogram parathyroideahormon i 71,4 mikroliter- injektionsvæske efter rekonstitution.
English: Each pre-filled pen contains 1050 micrograms of parathyroid hormone (rDNA) as powder in the first chamber and 1000 microlitres of solvent in the second chamber (corresponding to 14 doses).
Danish: Hver fyldt pen indeholder 1.050 mikrogram parathyroideahormon (rDNA) som pulver i det ene kammer og 1.000 mikroliter solvens i det andet kammer (svarende til 14 doser).
English: If you experience any of these side effects, contact your doctor right away.
Danish: Fortæl det med det samme til din læge, hvis du oplever en eller flere af disse bivirkninger.
English: Each dose contains 75 micrograms parathyroid hormone (rDNA) in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 75 mikrogram parathyroideahormon (rDNA) i 71,4 mikroliter-opløsning efter rekonstitution.
English: If you are concerned, call Shire at +44 (0)800 055 6614 for help.
Danish: Hvis du er bekymret, skal du ringe til Shire på +44 (0)800 055 6614 for at få hjælp.
English: Each pre-filled pen contains 1400 micrograms of parathyroid hormone (rDNA) as powder in the first chamber and 1000 microlitres of solvent in the second chamber (corresponding to 14 doses).
Danish: Hver fyldt pen indeholder 1.400 mikrogram parathyroideahormon (rDNA) som pulver i det ene kammer og 1.000 mikroliter solvens i det andet kammer (svarende til 14 doser).
English: Hypocalcaemia
Danish: Hypokalcæmi
English: Each dose contains 25 micrograms parathyroid hormone (rDNA) in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 25 mikrogram parathyroideahormon (rDNA) i 71,4 mikroliter-opløsning efter rekonstitution.
English: Each dose contains 50 micrograms parathyroid hormone (rDNA) in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 50 mikrogram parathyroideahormon (rDNA) i 71,4 mikroliter-opløsning efter rekonstitution.
English: Each dose contains 75 micrograms parathyroid hormone in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 75 mikrogram parathyroideahormon i 71,4 mikroliter- injektionsvæske efter rekonstitution.
English: Each dose contains 25 micrograms parathyroid hormone (rDNA)* in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 25 mikrogram parathyroideahormon (rDNA)* i 71,4 mikroliter injektionsvæske efter rekonstitution.
English: Each dose contains 50 micrograms parathyroid hormone in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 50 mikrogram parathyroideahormon i 71,4 mikroliter- injektionsvæske efter rekonstitution.
English: Each dose contains 25 micrograms parathyroid hormone in 71.4 microlitre solution following reconstitution.
Danish: Hver dosis indeholder 25 mikrogram parathyroideahormon i 71,4 mikroliter- injektionsvæske efter rekonstitution.
English: If leaking occurs, call Shire at +44 (0)800 055 6614 for help.
Danish: Hvis det forekommer, skal du ringe til Shire på +44 (0)800 055 6641 for at få hjælp.
English: Natpar 50 micrograms/dose
Danish: Natpar 50 mikrogram/dosis Rød etiket.
English: Pre-dose serum calcium
Danish: Serumcalcium før administration
English: It is also approved in Norway and Iceland.
Danish: Det er også blevet godkendt i Norge og Island.
English: The Member States competent authorities will continue to keep the product under regular review.
Danish: Medlemsstaternes kompetente myndigheder vil fortsat føre regelmæssigt tilsyn med produktet.
English: Elidel and associated names (See Annex 1)
Danish: Elidel og tilknyttede navne (se bilag I)
English: It was subsequently authorised by Mutual Recognition Procedure in all EU Member States except Ireland.
Danish: Senere blev det godkendt i henhold til den gensidige anerkendelsesprocedure i alle medlemsstater på nær Irland.
English: London, 29 May 2006 EMEA/262776/2005
Danish: London, den 29. maj 2006 EMEA/262776/2006
English: Oral explanations were given on 22 March 2006.
Danish: Der blev afgivet mundtlige redegørelser den 22. marts 2006.
English: International Non-Proprietary Name (INN): pimecrolimus
Danish: Internationalt fællesnavn ( INN): pimecrolimus
English: The Rapporteur and Co-Rapporteur appointed were Dr. Julia Dunne and Dr. Ingemar Persson, respectively.
Danish: Den udpegede rapportør og medrapportør var henholdsvis dr. Julia Dunne og dr. Ingemar Persson.
English: Pimecrolimus was first authorised in the EU in Denmark on 15 March 2002.
Danish: Pimecrolimus blev godkendt første gang i Den Europæiske Union i Danmark den 15. marts 2002.
English: Written explanations were provided by the Marketing Authorisation Holder by 30 June 2005, 15 July 2005, 19 July 2005, 20 December 2005 and 7 March 2006.
Danish: Indehaveren af markedsføringstilladelsen fremsendte skriftlige redegørelser den 30. juni 2005, 15. og 19. juli 2005, 20. december 2005 og 7. marts 2006.
English: The final opinion was converted into a Decision by the European Commission on 29 May 2006.
Danish: Den endelige udtalelse blev konverteret til en afgørelse truffet af Europa-Kommissionen den 29. maj
English: SUMMARY INFORMATION ON REFERRAL OPINION PURSUANT TO ARTICLE 31 OF COUNCIL DIRECTIVE 2001/83/EC, AS AMENDED, FOR
Danish: SAMMENFATTENDE OPLYSNINGER OM UDTALELSEN OM DEN INDBRAGTE SAG I HENHOLD TIL ARTIKEL 31 I RÅDETS DIREKTIV 2001/83/EF, MED SENERE ÆNDRINGER, OM
English: The referral procedure started on 21 April 2005.
Danish: Proceduren for indbragte sager blev indledt den 21. april 2005.
English: Pimecrolimus is a calcineurin inhibitor approved as cream formulation at a 1% concentration.
Danish: Pimecrolimus er en calcineurin-hæmmer, der er godkendt som cremeformulering med en koncentration på 1 %.
English: * Note: The information given in this document and Annexes reflect only the CHMP Opinion dated 23 March 2006.
Danish: Bemærkning: Oplysningerne i dette dokument og bilagene afspejler udelukkende CHMP's udtalelse af 23. marts 2006.
English: The CHMP recommended the restriction of use to these patients where treatment with topical corticosteroids is either inadvisable or not possible.
Danish: Derfor anbefalede CHMP at begrænse brugen til patienter, hvor behandling med topiske kortikosteroider enten ikke er tilrådelig eller ikke er mulig.
English: Pimecrolimus was initially approved for the use in patients with mild to moderate atopic dermatitis aged 2 years and over for short-term treatment of signs and symptoms and intermittent long-term treatment for prevention of progression to flares.
Danish: Pimecrolimus blev oprindelig godkendt til brug hos patienter med mild til moderat atopisk dermatitis (børneeksem) i alderen 2 år og derover til kortvarig behandling af tegn og symptomer samt til intermitterende langtidsbehandling for at forhindre progression til opblussen.
English: The list of product names concerned is given in the Annex I. The scientific conclusions are provided in the Annex II, together with the amended Summary of Product Characteristics, Labelling and Package Leaflet in the Annex III and the conditions of the marketing authorisations in the Annex IV.
Danish: Listen over de pågældende lægemiddelnavne fremgår af bilag I. De faglige konklusioner findes i bilag II, det ændrede produktresumé, etikettering og indlægsseddel i bilag III og betingelserne for markedsføringstilladelsen i bilag IV.
English: The reasons for referral concerned a review of the benefit/risk profile of medicinal products containing pimecrolimus considering efficacy and safety concerns with regards to the potential risk of cancer.
Danish: Grundlaget for indbringelsen var en gennemgang af benefit/risk- profilen for lægemidler indeholdende pimecrolimus, som skulle afklare spørgsmål vedrørende effekt og sikkerhed i forhold til den potentielle risiko for kræft.
English: On the grounds of safety and efficacy, the CHMP was of the opinion that pimecrolimus should be limited to second line use.
Danish: CHMP var på grundlag af oplysningerne om sikkerheden og virkningerne af den opfattelse, at pimecrolimus kun må anvendes som andenbehandling.
English: Based on evaluation of the available data and the Rapporteurs' assessment reports, the CHMP considered that the benefit/risk profile of pimecrolimus containing medicinal products remains favourable, and therefore adopted an opinion on 23 March 2006 recommending the maintenance of the Marketing Authorisations with amendments to the Summary of Product Characteristics, Labelling and Package Leaflet for pimecrolimus containing medicinal products.
Danish: CHMP var på baggrund af vurderingen af de foreliggende oplysninger og rapportørernes evalueringsrapporter af den opfattelse, at benefit/risk-forholdet for lægemidler indeholdende pimecrolimus fortsat er gunstigt og anbefalede derfor i en udtalelse af 23. marts 2006 at opretholde markedsføringstilladelserne med ændringer til produktresumé, etikettering og indlægsseddel for lægemidler indeholdende pimecrolimus.
English: On 21 April 2005, Denmark presented a referral to the EMEA under Article 31 of Directive 2001/83, as amended.
Danish: I henhold til artikel 31 i Rådets direktiv 2001/83/EF, med senere ændringer, indbragte Danmark den 21. april 2005 en sag for EMEA.
English: This overview was last updated in May 2018.
Danish: Denne oversigt blev sidst ajourført i maj 2018.
English: The dose is calculated according to the dog's weight.
Danish: Dosen beregnes ud fra hundens vægt.
English: These side effects are mild and generally short-lived.
Danish: Disse bivirkninger er milde og generelt kortvarige.
English: It should be used after careful evaluation of alternative treatment options;
Danish: Det bør anvendes efter nøje overvejelse af andre behandlingsmuligheder
English: Further information on Pexion can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Danish: Yderligere information vedrørende Pexion findes på agenturets websted under: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: Pexion received a marketing authorisation valid throughout the EU on 25 February 2013.
Danish: Pexion modtog en markedsføringstilladelse med gyldighed i hele EU den 25. februar 2013.
English: This may also help in controlling seizures.
Danish: Dette kan også være med til at kontrollere krampeanfaldene.
English: • reduce anxiety and fear associated with noise phobia.
Danish: • at reducere angst og frygt i forbindelse med støjfobi.
English: Pexion is a veterinary medicine used in dogs to:
Danish: Pexion er et veterinært lægemiddel, som anvendes hos hunde til:
English: Other information about Pexion
Danish: Andre oplysninger om Pexion
English: 25% of dogs did not respond to Pexion treatment and had the same or an increased number of seizures.
Danish: 25 % af hundene reagerede ikke på Pexion-behandling og havde det samme eller et øget antal anfald.
English: Pexion contains the active substance imepitoin.
Danish: Pexion indeholder det aktive stof imepitoin.
English: The European Medicine Agency decided that Pexion's benefits are greater than its risks and it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede, at fordelene ved Pexion opvejer risiciene, og at det kan godkendes til anvendelse i EU.
English: In case of accidental ingestion, especially by a child, medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Danish: Ved utilsigtet indtagelse, navnlig hos børn, skal der straks søges lægehjælp, og indlægssedlen eller etiketten skal vises til lægen.
English: Imepitoin's effect on GABA receptors also reduces fear and anxiety.
Danish: Imepitoins virkning på GABA-receptorerne reducerer også frygt og angst.
English: • reduce the frequency of generalised seizures (fits affecting most or all of the brain) due to epilepsy of unknown causes (idiopathic).
Danish: • at nedsætte hyppigheden af generaliserede krampeanfald (anfald, der omfatter det meste af eller hele hjernen) i forbindelse med såkaldt idiopatisk epilepsi (dvs. epilepsi af ukendt oprindelse).
English: An overview of Pexion and why it is authorised in the EU
Danish: En oversigt over Pexion, og hvorfor det er godkendt i EU
English: Why is Pexion authorised in the EU?
Danish: Hvorfor blev Pexion godkendt i EU?
English: What is Pexion and what is it used for?
Danish: Hvad er Pexion, og hvad anvendes det til?
English: Neurotransmitters such as GABA are chemicals that allow nerve cells to communicate with each other.
Danish: Signalstoffer som GABA er kemiske stoffer, som nervecellerne anvender til at kommunikere med hinanden.
English: Pexion must not be used in dogs with severely impaired liver, kidney or heart function.
Danish: Pexion må ikke anvendes hos hunde med svært nedsat lever-, nyre- eller hjertefunktion.
English: Pexion is available as tablets and can only be obtained with a prescription.
Danish: Pexion fås som tabletter og udleveres kun på recept.
English: This compared with a reduction of 2.4 seizures to 1.1 per month with phenobarbital (another anti-epileptic medicine).
Danish: Dette skal sammenholdes med en reduktion i krampeanfald fra 2,4 til 1,1 pr. måned ved behandling med phenobarbital (et andet lægemiddel mod epilepsi).
English: What are the risks associated with Pexion?
Danish: Hvilke risici er der forbundet med Pexion?
English: Out of 104 Pexion-treated dogs, 64% showed a good or excellent effect compared to 25% of 122 dogs receiving dummy treatment (placebo) as reported by owners.
Danish: Ud af 104 Pexion-behandlede hunde oplevede 64 % en god eller fremragende virkning sammenholdt med 25 % blandt de 122 hunde, der fik placebo-behandling (bedømt af ejerne).
English: Imepitoin also has a weak blocking effect on calcium channels.
Danish: Imepitoin virker desuden svagt blokerende på kalciumkanalerne.
English: During the evaluation phase of 12 weeks, 47% (30 out of 64) of Pexion-treated dogs were free from generalised seizures, whilst 58% (51 out of 88) of phenobarbital-treated dogs had no seizures.
Danish: I evalueringsfasen på 12 uger var 47 % (30 ud af 64) af de Pexion-behandlede hunde fri for generaliserede krampeanfald, mens 58 % (51 ud af 88) af de phenobarbital-behandlede hunde var uden anfald.